1. Home
  2. IMTX vs AZTA Comparison

IMTX vs AZTA Comparison

Compare IMTX & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immatics N.V.

IMTX

Immatics N.V.

HOLD

Current Price

$9.16

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Azenta Inc.

AZTA

Azenta Inc.

HOLD

Current Price

$37.45

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMTX
AZTA
Founded
N/A
1978
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
IMTX
AZTA
Price
$9.16
$37.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$19.25
$43.20
AVG Volume (30 Days)
464.2K
649.7K
Earning Date
11-17-2025
02-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$99,445,031.00
$593,821,000.00
Revenue This Year
N/A
$6.13
Revenue Next Year
$19.39
$5.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.55
52 Week Low
$3.30
$23.91
52 Week High
$12.41
$55.64

Technical Indicators

Market Signals
Indicator
IMTX
AZTA
Relative Strength Index (RSI) 39.70 64.76
Support Level $9.13 $36.86
Resistance Level $10.19 $38.55
Average True Range (ATR) 0.49 1.08
MACD -0.12 0.28
Stochastic Oscillator 13.78 82.53

Price Performance

Historical Comparison
IMTX
AZTA

About IMTX Immatics N.V.

Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

About AZTA Azenta Inc.

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

Share on Social Networks: